The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors
Open accessAbstract
Production of human mesenchymal stem cells for allogeneic cell therapies requires scalable, cost‐effective manufacturing processes. Microcarriers enable the culture of anchorage‐dependent cells in stirred‐tank bioreactors. However, no robust, transferable methodology for microcarrier selection exists, with studies providing little or no reason explaining why a microcarrier was employed. We systematically evaluated 13 microcarriers for human bone marrow‐derived MSC (hBM‐MSCs) expansion from three donors to establish a reproducible and transferable methodology for microcarrier selection. Monolayer studies demonstrated input cell line variability with respect to growth kinetics and metabolite flux. HBM‐MSC1 underwent more cumulative population doublings over three passages in comparison to hBM‐MSC2 and hBM‐MSC3. In 100 mL spinner flasks, agitated conditions were significantly better than static conditions, irrespective of donor, and relative microcarrier performance was identical where the same microcarriers outperformed others with respect to growth kinetics and metabolite flux. Relative growth kinetics between donor cells on the microcarriers were the same as the monolayer study. Plastic microcarriers were selected as the optimal microcarrier for hBM‐MSC expansion. HBM‐MSCs were successfully harvested and characterised, demonstrating hBM‐MSC immunophenotype and differentiation capacity. This approach provides a systematic method for microcarrier selection, and the findings identify potentially significant bioprocessing implications for microcarrier‐based allogeneic cell therapy manufacture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“Pioneering work in the 1970s led to the isolation and identification of mesenchymal stem/stromal cells (MSCs) [1, 2]; these cells are now considered to be a promising candidate for cell-based therapies, tissue engineering and regenerative medicine applications due to their multipotency, propensity to grow in vitro, pr…”
BackgroundReactor Engineering in Large Scale Animal Cell Culture
Nienow, A. W. (2006) · Cytotechnology · doi:10.1007/s10616-006-9005-8 · Cited by 433 · cited 2×
“This is not unexpected as it is widely acknowledged that agitation generates a homogenous physical and chemical environment by improving mass transfer and reducing concentration gradients [18].”
BackgroundMethodSelf-citationBardy, J., Chen, A. K., Lim, Y. M., Wu, S., Wei, S., Weiping, H., Chan, K., Reuveny, S., & Oh, S. K. W. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0146 · Cited by 111
Cited by
Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell‐free therapy
Phan, J., Kumar, P., Hao, D., Gao, K., Farmer, D., & Wang, A. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1522236 · Cited by 333
Advances and challenges in stem cell culture
McKee, C., & Chaudhry, G. R. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.051 · Cited by 323
Microcarriers for Upscaling Cultured Meat Production
Bodiou, V., Moutsatsou, P., & Post, M. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00010 · Cited by 272
Needle to needle robot‐assisted manufacture of cell therapy products
Ochs, J., Hanga, M. P., Shaw, G., Duffy, N., Kulik, M., Tissin, N., Reibert, D., Biermann, F., Moutsatsou, P., Ratnayake, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10387 · Cited by 18
Self-citationDesign of cell expansion processes for adherent‐growing cells with mDoE‐workflow
Kuchemüller, K. B., Pörtner, R., & Möller, J. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202200059 · Cited by 4
Metadata
- Authors
- Rafiq, Q. A., Coopman, K., Nienow, A. W., & Hewitt, C. J.
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2016-02-29
- Volume
- 11
- Issue
- 4
- Pages
- 473-486
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2185766664
- Cited by
- 161
- References
- 4
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. https://app.cochat.ai/papers/10.1002/biot.201400862
- The paper
- Rafiq, Q. A., Coopman, K., Nienow, A. W., & Hewitt, C. J. (2016). Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. Biotechnology Journal. https://doi.org/10.1002/biot.201400862
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.